The cloned Kv1.5 K+ channel displays similar kinetics and pharmacology to a delayed rectifier channel found in atrial myocytes. To determine whether the Kv1.5 isoform plays a role in the cardiac action potential, it is necessary to confirm the expression of this channel in cardiac myocytes. Using antibodies directed against two distinct channel epitopes, the Kv1.5 isoform was localized in human atrium and ventricle. Kv1.5 was highly localized at intercalated disk regions as determined by colocalization with connexin and N-cadherin specific antibodies. While both antichannel antibodies localized the Kv1.5 protein in cardiac myocytes, only the NH2-terminal antibodies stained vascular smooth muscle. The selective staining of vasculature by this antiserum suggests that epitope accessibility, and perhaps channel structure, varies between cardiac and vascular myocytes. Kv1.5 expression was localized less in newborn tissue, with punctate antibody staining dispersed on the myocyte surface. This increasing organization with age was similar to that observed for connexin. Future work will address whether altered K+ channel localization is associated with cardiac disease in addition to changing with development. (J. Clin. Invest. 1995. 96:282-292.)
Introduction
The electrically excitable cells of the heart display a complex and unique action potential resulting in part from the differential expression of various ion channel isoforms. Probably the most diverse group of ion channels within the heart are the K+ channels responsible for repolarization. At least five functionally distinct voltage-gated K+ currents have been described in mammalian heart (1, 2) . However, the presence of multiple overlapping currents in cardiac myocytes complicates the study of individual K+ channels. While the traditional approach uses a combination of holding potential modulation, ion substitution, and pharmacological dissection to eliminate all but the current of interest, molecular cloning and cDNA expression technologies have permitted the study of a single cloned isoform in the expression system of choice. However, this approach poses a new challenge in terms of correlating the cloned channels with specific cells and endogenous currents.
At least six different, Shaker-like, K+ channels have been cloned from rat (3) , mouse (4) , ferret (5) , or human heart (6, 7) and functionally expressed in heterologous expression systems. Of these, the channel designated Kvl.5 is the most cardiac specific from both a developmental and tissue-specificity standpoint (2, 8) . Kvl.5 has been cloned also from skeletal (9) and smooth muscle (10) , indicating that this isoform is expressed in a variety of muscle cell types. Upon expression of the Kvl.5 clone in either mouse fibroblasts (11) , HEK 293 cells (7) , or Xenopus oocytes (12) , this cDNA produces a delayed rectifier-like current with kinetic properties and pharmacology similar to an endogenous cardiac myocyte current described by Boyle and Nerbonne in rat atrium (13) and by Nattel and co-workers in human atrial cells (14) . However, the mere resemblance in kinetics is not sufficient to correlate this clone with the endogenous current. The pharmacology is also insufficient since many voltage-gated channels share pharmacological properties. A greater problem is the finding that Shakerlike K+ channel proteins form heteromeric structures both in heterologous expression systems ( [15] [16] [17] [18] and in vivo ( 19, 20) . These heteromeric channels have functional and pharmacological properties distinct from the respective homomeric channels. There is also the more recent finding that function-altering beta subunits exist which can convert cloned channels with delayed rectifier properties into ones that rapidly inactivate (21 ) . Therefore, correlation of Kvy.5 with an endogenous current ultimately requires the modulation of the native current by interventions specific for the Kvl.5 isoform, such as function-altering, isoform-specific antibodies, antisense cRNA approaches, dominant-negative strategies, or gene knockouts in transgenic animals. However, before any of these approaches are undertaken, it is prudent to first confirm that the Kvl.5 channel protein is present in cardiac myocytes.
We report here the localization of the hKvl.5 channel protein in human atrial and ventricular myocardium obtained from newborn and adult patients. In the adult tissue, the channel was not evenly distributed over the myocyte surface but rather was localized in regions of high density within the intercalated disks. This pattern changed with development, with a more dispersed staining pattern observed in newborn tissue as compared with adult myocardium. While 1) were chosen for antibody production. These epitopes were predicted to be antigenic in the rabbit since the sequence shows some species variation when comparing channels cloned from human and rat. However, the sequence in these regions is confined to the Kvl.5 isoform and was predicted to produce isoform-specific antibodies. For amino acid sequence comparisons between Kvl K+ channel subfamily isoforms see references 1, 3, and 22. Blast searches of the GenBank and EMBL databases indicated that only the mouse, rat, and canine Kvl.5 K+ channels showed significant identity with the NH2-terminal epitope, while only the mouse and rat homologues showed significant identity with the S1-S2 epitope. Antiserum against the S1-S2 epitope ( Fig. 1 ) was produced in rabbits using a synthetic peptide, LLRHPPAPHQPPA-PAPGANGSGVMA, as described previously (23 (25, 26 ). The antisera were tested by immunofluorescent staining of Kvl.5-transfected L cells as described below. Affinity purification was performed using native GSH-T and GSH-T channel fusion proteins covalently bound to Sepharose as described previously (24) . Briefly, the antiserum was passed first over the GSH-T-Sepharose columns to remove antibodies against the carrier protein. (24) . The construction of a Kvl.5 truncation lacking the 57 COOH-terminal amino acids has been described previously (27) (11) . L cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% horse serum, 100 U/ml penicillin G, 0.1 mg/ml streptomycin with 0.25 mg/ml G418, under a 5% CO2 atmosphere. The transfected L cells were grown on poly-L-lysine-coated, UV-sterilized glass cover slips, and incubated overnight with 4 AM dexamethasone to induce Kvl.5 channel expression. The cells were not fixed, and the coverslips were not removed from their tissue culture dishes until ready for microscopic examination to prevent cell detachment. To reduce bacterial contamination during the experiment, all incubations included 0.08% sodium azide, 100 U/ml penicillin G, 0.1 mg/ ml streptomycin, and 0.05 mg/ml gentamicin. The cover slips were washed gently with PBS and then incubated for 1 h 15 min at room temperature with primary antiserum diluted 1:1,000 in PBS plus 10% goat serum and 0.25% saponin. The cells were taken through 3 2-min washes with PBS plus 10% goat serum, then incubated for 30 min at room temperature with biotin-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted 1:200 in PBS plus 1.5% goat serum. Another wash series with PBS was followed by a final incubation for 30 min at room temperature with CY3-conjugated streptavidin (Jackson ImmunoResearch Laboratories) diluted 1:200 in PBS plus 1% BSA. The coverslips were then wet mounted in PBS on hanging drop glass slides and examined immediately. Channel-free, sham-transfected cells served as controls for background staining levels.
Immunostaining ofheart tissue cryosections. 10-Am cryosections of both human and rat heart were cut using a Bright Cryostat (model B2435; Hacker Instruments Inc., Fairfield, NJ). The following wash and blocking steps were performed in Columbia staining jars while the antibody and fluorochrome incubations were performed in a humidity chamber. The sections were collected on gelatin-coated coverslips, dried for 5-10 min at room temperature, and washed three times, 10 min each, in PBS. The tissue was then treated with 0.5% CHAPS (3-[(3-cholamidopropyl)-dimethylammonio]-1-propane-sulfonate hydrate) in PBS with three solution changes, 10 min each. The tissue was washed again with PBS (3 X 10 min) to remove CHAPS, and then blocked overnight at 4TC in PBS containing 10% goat serum and 5% nonfat dry milk. After the overnight block, the tissue was incubated in primary antiserum diluted in PBS plus 10% goat serum, 0.5% CHAPS, and 0.25% saponin, for 1.5 h at room temperature. The tissue was washed three times for 10 min each with PBS plus 10% goat serum and 0.5% CHAPS, followed by 1 10-min wash with PBS alone. Endogenous avidin and biotin were blocked using the avidin/biotin blocking kit (Vector Laboratories, Burlingame, CA) according to the manufacturer's recommendations. The sections were then incubated with biotin-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories) diluted 1:200 in PBS plus 1.5% goat serum for 30 min at room temperature. The tissue was washed (3 X 10 min) with PBS plus 0.5% CHAPS and incubated with CY3-conjugated streptavidin (Jackson ImmunoResearch Laboratories) diluted 1:200 in PBS containing 0.5% CHAPS and 1% BSA for 45 min at room temperature. The coverslips were washed a final time with PBS plus 0.5% CHAPS and, if no further staining was to be performed, mounted on glass slides using Aqua-PolyMount (Polyscience, Warrington, PA) and allowed to dry overnight before microscopic examination.
Immunogen block of tissue staining. Preabsorption of S1-S2 linker antibody with peptide immunogen was used to demonstrate binding specificity of this antibody. Staining was performed as described above, except that alternate cryostat sections were stained with S1-S2 antiKvl.5 primary antiserum that had been preincubated for 2 h at room temperature with 150-200 nmol of the S1-S2 peptide per milliliter of diluted antiserum (1:1,000). The control slices were stained with Si-S2 anti-Kvl.5 antiserum that underwent the same 2-h incubation at room temperature, minus the S1-S2 peptide. Preabsorption of NH2-terminal antibody with GSH-T fusion protein construct was used to demonstrate binding specificity of this antibody. Alternate slices were stained with NH2-terminal anti-Kvl.5 antiserum, or affinity-purified antibody, that had been preincubated overnight at 4°C with 40 nmol of the NH2-terminal fusion protein construct (112 NH2-terminal amino acids coupled to bacterially synthesized GSH-T per milliliter of antisera (diluted 1:1,000) or affinity-purified antibody (diluted to 2 pg/ml). The control slices were stained with NH2-terminal anti-Kvl.5 antiserum or affinity-purified antibody that underwent the same overnight incubation, either minus the fusion protein construct or with the GSH-T carrier alone. Identical results were obtained in both controls.
Colocalization of KvJ.5, connexin, and N-cadherin antibody binding. Mouse anti-connexin-43 was obtained from Zymed Laboratories (South San Francisco, CA), and rabbit anti-pan cadherin was obtained from Sigma Immunochemicals. These antibodies produced well characterized staining patterns when used separately (28-31) (data not shown). For the connexin colocalization, the immunostaining with the anti-Kvl.5 antibody was performed as described above, but instead of immediate microscopic examination the tissue was incubated overnight at 4°C with the anticonnexin primary antibody (diluted 1:500-1:5,000) in PBS plus 1.5% goat serum. The tissue was taken through 3 10-min washes with PBS containing 10% goat serum and 0.5% CHAPS, then washed 3 times, 10 min each, with PBS containing 0.5% CHAPS alone. A final incubation of the tissue was in BODIPY FL goat anti-mouse IgG fluorophore (Molecular Probes, Inc., Eugene, OR) diluted 1:100 in PBS plus 0.5% CHAPS and 1% BSA. After a final wash (3 x 10 min), the slides were mounted and examined. Standard controls were included to determine the staining levels of the secondary antibodies in the absence of primary antibodies and to confirm that the secondary antibodies did not crossreact between species in terms of detecting the primary rabbit and mouse antibodies. Staining with individual antibodies was also performed to confirm that the staining patterns observed in the single-and double-stained sections were identical. Since the anticadherin antibodies and both of the Kvl.5 antisera were raised in rabbit, this colocalization required additional blocking steps as described previously in detail for same-species, dual immunohistochemistry (32) . The immunostaining with the anti-Kvl.5 antibody was performed as described above, followed by a 1-h room temperature blocking incubation with a rabbit serum that did not stain heart above background levels. This step saturated any remaining rabbit IgG binding sites on the secondary antibody used to detect the Kvl.5 antibody staining. The tissue was then washed with PBS plus 0.5% CHAPS (3 x 10 min) and incubated for 1 h at room temperature with goat anti-rabbit IgG F(ab' )2 fragments (Jackson ImmunoResearch Laboratories) diluted 1:30 in PBS plus 1.5% goat serum. This blocking step masked F(c) regions on any bound rabbit IgG. The wash was repeated and the tissue was incubated overnight at 40C with the cadherin antibody (diluted 1:2,000-1:8,000) in PBS plus 1.5% goat serum. The tissue was washed with PBS containing 10% goat serum and 0.5% CHAPS (3 X 10 min) and then washed again with PBS containing 0.5% CHAPS alone (3 X 10 min). The final incubation of the tissue was in BODIPY FL goat anti-rabbit IgG fluorophore (Molecular Probes, Inc.) diluted 1:100 in PBS plus 0.5% CHAPS and 1% BSA. A final wash series was performed (3 x 10 min) and the slides were mounted and examined. Several control slices were included to determine that the blocking steps outlined above were successful, i.e., that the last secondary antibody did not bind to available first round primary or secondary antibodies and that the blocking antibodies did not recognize any proteins in heart. Single staining was also performed to compare the staining patterns with those obtained in the double-stained sections.
Results
Characterization of the KvJ.S channel in transfected tissue culture cells. Western blot analysis of transfected L cell membranes was performed to characterize the two antisera as shown in Fig. 2 . Both the S 1-S2 and NH2-terminal antibodies specifically detected the Kvl .5 channel protein (64,000 Mr, see arrow) in hKvl.5-expressing cells (lanes I and 4) but not in shamtransfected cells (lanes 3 and 6). Lanes 2 and 5 contained membranes from cells expressing a truncated form of hKvl.5 (27) lacking the 57 COOH-terminal amino acids. The band detected by both antibodies had the predicted increase in electrophoretic mobility for the truncated channel.
Before Fig. 3, A (Fig. 3 B) showed no detectable surface staining under these conditions, indicating binding specificity. Fixation in 1% paraformaldehyde or acetone prevented detection of cell surface channels (data not shown). The S1-S2 antibody was species specific in that it did not stain L cells expressing the rat Kvl.5 clone, even though equivalent current amplitudes were obtained (data not shown).
Since this antibody recognizes an extracellular epitope, staining was also performed with live cells in the absence of membranepermeabilizing reagents. As expected, a cell surface pattern similar to that shown in Fig. 3 A was obtained (data not shown). terminal antibody and the hKvl.5-and sham-transfected cells, respectively. In contrast to the S 1-S2 antibody, the NH2-terminal serum did recognize the rat Kvl.5 channel in transfected L cells (data not shown), an unexpected finding since the NH2-terminal epitope sequence differed more between the two species than did the S 1-S2 linker epitope (see Fig. 1 B) . The lower magnification shown in Fig. 3 C further illustrates the heterogeneity in staining intensity. Immunofluorescent staining of cells expressing the truncated hKvl.5 produced patterns identical to those shown in Fig. 3 , A and C (data not shown).
Localization of the KvJ.5 channel in human myocardium. The Kv 1.5-like currents recorded from native human atrial myocytes are 0.4 nA in amplitude at 50 mV (14) . The fluorescence signal obtained from the transfected, Kvl.5-expressing tissue culture cells suggested that the immunofluorescence approach used here should detect the endogenous channel protein in sectioned human myocardium. Therefore, unfixed cryosections were prepared from six different adult human atrium and ventricle samples and stained with the S1-S2 antibody as described in Methods. As shown in Fig. 4 A, the channel was localized to two types of myocyte surface regions in human left atrial appendage. Binding was detected at both the ends of the myocytes near the intercalated disk and along the sides of some myocytes, especially near points of contact with adjacent myocytes. This labeling pattern was not observed when the peptide antigen was preincubated with the diluted S1-S2 antibody before staining the tissue section (Fig. 4 C) . The localization observed in adult human ventricular muscle (left ventricular free wall) is shown in Fig. 4 D and was similar to that observed in atrium except that little longitudinal staining was seen. Again, the staining was completely blocked by preincubation with the peptide antigen as shown in Fig. 4 likely possibility that the S1-S2 antiserum was crossreacting with a related nonchannel epitope present at the intercalated disk, a second antibody directed against a different region of the Kvl.5 channel was produced. The NH2-terminal antibody was produced against the 112 NH2-terminal amino acids coupled to bacterially synthesized GSH-T as described in Methods. This antibody was affinity purified to reduce staining background and all results obtained with the affinity-purified materials were also obtained with the antiserum. Fig. 5 shows the localization of the Kvl.5 channel in both human atrial and ventricular myocytes (A and D, respectively). The patterns are essentially the same as those observed with the S1-S2 antibody except that the NH2-terminal-terminal antibody also stained vascular tissue (Fig. 5 A, arrow) . Examination of antibody binding to human aorta suggests that this binding is to the vascular smooth muscle within the medial layers (data not shown). The staining of both the blood vessels and cardiac myocytes was completely blocked by incubation with the channel sequence containing fusion protein (Fig. 5, C  and F Fig. 6 , A-C, respectively. As shown in Fig. 6 C, the red signal locating the channel is often associated with the green signal marking the cadherin location. Where complete colocalization is seen, the observed color is yellow due to the combination of the two primary signals. The patterns are not identical and often the two signals are not associated. Similar results were obtained when the Kvl .5 channel was colocalized with connexin in atrium (data not shown).
Human adult ventricular sections were stained also with both intercalated disk markers and the Kvl.5 antibody. Fig. 6 , D-F, shows the staining of ventricular sections with SI-S2 Kvl.5 antiserum and the connexin antibody, individually and together. As shown in Fig. 6 F, the extent of colocalization between the intercalated disk marker and Kvl.5 in ventricle is much greater than that observed in atrium. In ventricle almost all the channels were associated with the connexin. Note the disk captured in cross section (arrow) in Fig. 6 F, illustrating the close association between the Kvl1.5 and gap junction channels. When cadherin and Kvl.5 were colocalized in ventricle, the tight association between the two signals was also seen (data not shown).
The KvJ.S localization pattern changes with development. The data presented in Fig. 6 confirm that the Kvl.5 channel is tightly associated with intercalated disk proteins in both human adult atrium and ventricle. Since newborn myocardium from both human (28) and rat (33) has a poorly defined disk structure compared with the adult, and Kvl.5 is localized near the disk, the localization of the channel in newborn myocardium was examined. Fig. 7 shows the localization of connexin and Kvl.5 in newborn ventricle (A and B., respectively). Both proteins are localized in a diffuse pattern on the cell surface, in some cases almost outlining the cell. The connexin localization shown in Fig. 7 A is similar to the patterns described previously for the localization of connexin in rat and human newborn heart (28, 33) . In contrast to the diffuse pattern in Fig. 7, A and B, Fig.  7 , C and D, shows the staining of adult human ventricle with the connexin and Kvl.5 antibody, respectively. In these two panels the standard intercalated disk pattern is seen, indicating that the Kvl.5 localization changes during development, probably in parallel with the connexin protein.
Localization of the KvJ.S channel in rat heart. While the SI-S2 antibody did not recognize the rat homologue of Kvl.5 after expression in tissue culture cells, the NH2-terminal antibody did. Therefore, this antibody was used to stain rat ventricular cryosections as shown in Fig. 8 A. The intercalated disk pattern was obtained in addition to staining of blood vessels. Staining of both cell types was blocked by the appropriate fusion protein (data not shown). A human atrial cryosection stained with the NH2-terminal antibody is shown in Fig. 8 B for compar- ison.
Discussion
The KvJ.S K+ channel is expressed in human and rat cardiac myocytes at the intercalated disk. The immunofluorescence data presented in Figs. 4 and 5 clearly show that the Kvl.5 channel is expressed in both atrial and ventricular myocytes. A similar pattern of expression was observed in rat heart as shown in Fig.  8 . While it is difficult to quantitate the fluorescent signal, the amount of channel expressed in atrium and ventricle of both species appeared similar, although at times it appeared as though more staining occurred in atrium. One possibility is that as channel density increases the efficiency of antibody binding decreases, making it difficult to compare fluorescence intensities between different cardiac regions. In rat heart the Kvl.5 transcript is equally distributed between these two regions based on Northern blot (3) and RNase protection analysis (34) . Northern analysis suggests that the Kvl.5 channel is more abundant in human atrium than in ventricle (2, 6) while a PCR-based analysis suggests the levels are similar between human atrium and ventricle (7) . The steady state level of the Kvl.5 transcript in rat heart is altered by.several interventions. Kvl.5 channel mRNA is downregulated as a function of hypertrophy (35) and levels decreased eightfold in ventricles of adrenalectomized animals (36) . Dexamethasone treatment of these animals increased ventricular Kvl.5 mRNA 50-fold, with no effect on mRNA levels in atrium (36 Adult rat heart cryosections were prepared and stained with the NH2-terminal affinity-purified antibody as described in Methods (A). Cryosections from human atrium stained with the same antibody are shown for comparison (B) . The structures indicated with the arrows represent blood vessels. The bars represent 25 /Lm. whole tissue preparations were not successful despite repeated attempts.
Immunolocalization data on rare membrane proteins must be evaluated critically. Since channel proteins are often present at surface densities of several molecules per square micron, the slightest epitope crossreactivity with a more abundant membrane protein will produce the anticipated fluorescence signal. One region of the cardiac myocyte that is enriched in protein and thus is a good candidate for producing such nonspecific signals is the intercalated disk. It is for these reasons that we have relied on the localization of the Kvl.5 channel with two antibodies made against distinct regions of the channel, the NH2-terminal and the S1-S2 linker. The likelihood that both antibodies are crossreacting with related epitopes associated with the intercalated disk is remote, especially since the Si-S2 antibody is species specific. It does not recognize the rat homologue of Kvl.5 and does not stain rat heart. The NH2-terminal antibody does recognize the channel from both species in transfected cells and does stain rat and human heart.
Voltage-clamp recordings have detected outward currents in human atrial myocytes that resemble Kvl.5 when expressed in heterologous systems (14) , an observation consistent with the localization of the Kvl.5 protein to human atrial myocytes. However, even though the present study finds the Kvl.5 protein in human ventricular myocytes, corresponding whole cell voltage-clamp currents have not been found in these cells (37) . Since Kvl family members can have their function and pharmacology significantly altered by heterotetramer formation (15) and beta subunit composition (21) , it is possible that the Kvl.5 protein forms a homomeric channel in atrium while forming a heteromeric channel in ventricle, perhaps in association with function altering beta subunits. The I, current observed in human ventricular cells differs from that observed in atrium (37) . Perhaps this ventricular 'to is due to a heteromeric or beta subunit-associated Kvl.5 channel while the atrial delayed rectifier current is due to homomeric Kvl.5. Recently, we cloned additional beta subunits from human ventricle that alter the inactivation kinetics of Kvl.5 after coexpression in Xenopus oocytes (England, S. K., V. N. Uebele, H. Shear, K. Jayaveera, P. B. Bennett, and M. M. Tamkun, manuscript submitted for publication). It will be important to determine whether these beta subunits colocalize with the Kv1.5 channel in human ventricle but not in atrium.
The cell surface distribution of KvJ.S varies with development. Fig. 7 indicates that the localization of the Kvl.5 channel in human myocardium changes drastically as a function of patient age. In newborn myocardium (1 or 2 mo old) the channel is distributed in a punctate manner over the cell surface with little localization into structures resembling the intercalated disk of the adult. While developmental issues have not been examined in human heart, several studies have compared the cardiac myocyte K + currents found in fetal, neonatal, and adult animals. Inward rectifier K + current in the rabbit increases > 2-fold between fetal days 21 and 28 and 1.6-fold between the neonate and adult stages (38) . The cardiac myocytes of neonatal dogs lack the transient outward current which does not appear until approximately day 60 (39). In the rabbit these transient outward currents not only increase in magnitude between neonatal and adult stages but they also show kinetic differences, suggesting that either different isoforms are expressed or that there is agespecific modulation of the same isoform (40) .
The distribution of gap junctions, as visualized by staining with connexin-specific antibodies, is also poorly organized early in life relative to the adult pattern (Fig. 7, A (Fig. 8) . This finding was not completely unexpected since the Kvl.5 mRNA is found in rat thoracic aorta (3), arguing for the presence of this channel in the vasculature. Kvl.5-like currents exist in rabbit and canine vascular smooth muscle at a cell surface density greater than that found in human cardiac myocytes (14, 42, 43) . The canine homologue of Kv1.5 has been cloned recently from colonic smooth muscle and found to be abundantly expressed in both gastrointestinal and vascular smooth muscle (10) . In addition, Koren and co-workers (44) have reported localization of the rat Kvl.5 protein to the cardiac vasculature. These investigators have reported also that both rat cardiac myocytes and vascular smooth muscle cells contain the Kvl.5 mRNA based on in situ hybridization (44) . Therefore, even though the localization to the human vasculature reported here was performed with only a single antiserum, it is likely that this channel is expressed in vascular smooth muscle. Perhaps the S1-S2 and NH2-terminal antibodies, which recognize very different epitopes, do not both stain the vessels because the channel structure differs between cell types, with the S1-S2 epitope being exposed only in the myocyte. The vascular myocyte could have a heterotetramer subunit composition that is incompatible with Sl-S2 antibody binding. Alternatively, since the S1-S2 epitope contains an Nlinked glycosylation site, perhaps altered glycosylation in the vasculature blocks antibody binding. Region-specific masking of ion channel epitopes has been documented. For example, two monoclonal antibodies recognizing different NH2-terminal epitopes on the skeletal muscle voltage-gated Na' channel differentially stain the surface membrane and T-tubular system (45) . It appears that the epitope for one antibody is accessible in both membrane systems while the other is exposed only on the surface membrane. If such heterogeneity can occur within the same cell, it is likely to also occur between cells. Another explanation for the differential staining of vessels with the Kvy.5-specific antibodies is that an undiscovered channel exists in the vasculature which shares sequence identity with Kvl.5 in the NH2-terminal epitope.
Functional implications for K+ channel expression at regions of cell-cell contact. The Kvl.5 channel in both rat and human is concentrated at regions of cell-cell contact, near the intercalated disk protein cadherin and adjacent to connexin. Given the length constants in the cardiac myocyte there is no functional reason to concentrate the Kv1.5 channel, or another voltage-gated ion channel, at the regions of intercellular communication. However, there is no reason why the channels cannot be concentrated here. Voltage-gated sodium channels have been reported to be concentrated here (46) even though the inward current in a neighboring myocyte is capable of depolarizing the adjacent cell even in the complete absence of Na+ channels. Also believed concentrated at the disk region are membrane proteins such as IP3 receptors (47) and, to a certain extent, glucose transporters (48) . Perhaps this region of the myocyte is suited best for anchoring channel proteins to the cytoskeleton. The membrane cytoskeleton may be simply more stable in this region. Alternatively, the biosynthetic mechanisms for inserting the nascent channels into the surface membrane may concentrate channel protein here for reasons unrelated to channel function. The Kvl.5 channel may exist at low density outside the intercalated disk, being evenly distributed over the cell surface. If such surface density was less than one channel per several square microns, detection by the fluorescence technique used here may not be possible given the nonspecific background binding evident in Figs. 4 and 5. Conclusion. For reasons that are not completely clear, the Kvl.5 K' channel is localized at the intercalated disk regions in human and rat myocardium. These data are the first description of the cell surface localization of any voltage-gated K+ channel in human muscle and confirm that the Kvl.5 channel is likely to play a role in the cardiac action potential. The expression patterns are similar between atrium and ventricle and vary in both regions with development, consistent with the idea that alterations in Kvl.5 expression are in part responsible for changes in myocyte electrical properties as a function of development. The channel is expressed also in vascular smooth muscle, suggesting it may modulate vascular tone. The localization of Kvl.5 expression in specific cardiac regions such as the SA node and conducting system remains to be determined as do the cell-specific changes in expression that occur during ischemia, hypertrophy, and hypertension. A more challenging task will be the determination of the subunit composition of the Kvl.5 protein-containing complex in cardiac and vascular myocytes.
